Compare ENGN & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ENGN | USCB |
|---|---|---|
| Founded | 1999 | 2002 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 332.5M |
| IPO Year | N/A | 2021 |
| Metric | ENGN | USCB |
|---|---|---|
| Price | $8.57 | $19.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $22.71 | $22.00 |
| AVG Volume (30 Days) | ★ 314.7K | 50.2K |
| Earning Date | 12-19-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.09% |
| EPS Growth | N/A | ★ 50.85 |
| EPS | N/A | ★ 1.57 |
| Revenue | N/A | ★ $92,331,000.00 |
| Revenue This Year | N/A | $26.26 |
| Revenue Next Year | N/A | $13.21 |
| P/E Ratio | ★ N/A | $12.20 |
| Revenue Growth | N/A | ★ 28.61 |
| 52 Week Low | $2.65 | $15.39 |
| 52 Week High | $11.14 | $20.49 |
| Indicator | ENGN | USCB |
|---|---|---|
| Relative Strength Index (RSI) | 56.36 | 59.79 |
| Support Level | $7.57 | $18.87 |
| Resistance Level | $8.47 | $19.95 |
| Average True Range (ATR) | 0.64 | 0.63 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 63.69 | 63.49 |
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.